Close Menu

NEW YORK – Immune disease prognostic firm PredictImmune announced on Thursday a collaboration with the Crohn's & Colitis Foundation to validate the company's PredictSure IBD test in a diverse patient population.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.